We are open to partnering, contact our team at
Poolbeg Pharma plc is a biopharmaceutical company committed to the development and commercialisation of our innovative medicines that address critical unmet medical needs. We are actively seeking partners for our pipeline of ground-breaking programmes and are open to partnering or licensing discussions.
What it’s like to work with us
“Now that our influenza disease model has been enriched by Poolbeg’s unparalleled data, we are excited to evaluate the novel disease mechanisms on our platform. This will potentially identify drug targets that can be used to develop treatments for influenza, a significant global health threat, in a much shorter time-frame and more cost effectively than with traditional reductionist analysis and drug discovery techniques.”
David Harel
CEO of CytoReason
Neel S. Madhukar, PhD
CEO of OneThree Biotech
“We are very pleased to be working with Poolbeg and to have the opportunity to deploy the ATLANTIS platform to complete the first ever AI-driven analysis of RSV disease progression data. I am delighted that Poolbeg’s unique dataset combined with OneThree’s externally validated platform have now delivered new actionable insights surrounding disease biology and drug discovery that can bring much needed treatment options for both the young and the elderly; the most vulnerable to RSV infection.”
